This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shapiro, R. L. Articles by Rifkin, D. B. Search for Related Content PubMed PubMed Citation Articles by Shapiro, R. L. Articles by Rifkin, D. B.

American Journal of Pathology, Vol 150, 359-369, Copyright © 1997 by American Society for Investigative Pathology

REGULAR ARTICLES

Urokinase-type plasminogen activator-deficient mice are predisposed to staphylococcal botryomycosis, pleuritis, and effacement of lymphoid follicles

RL Shapiro, JG Duquette, I Nunes, DF Roses, MN Harris, EL Wilson and DB Rifkin
Department of Surgery, New York University Medical Center 10016, USA.

Urokinase-type plasminogen activator (uPA) is thought to be an important mediator in the proteolytic degradation of extracellular matrix components observed in a wide variety of normal physiological and pathological conditions. However, the phenotype of a recently developed strain of urokinase-deficient (uPA-/-) mice appears to be normal when maintained under ideal nonstressful conditions. We report an outbreak of botryomycosis, an unusual staphylococcal infection, in a colony of uPA-deficient mice. A detailed histological examination of these uPA-deficient animals also revealed a variety of previously unreported phenotypic abnormalities such as pleuritis and the effacement of lymphoid follicles in the regional lymph nodes and spleen. Additional phenotypic abnormalities such as dystrophic calcifications and rectal prolapse were also observed in the uPA- deficient population. These abnormalities were also noted in ostensibly healthy uPA-deficient animals. Botryomycosis did not affect a colony of wild-type (uPA+/+) animals maintained concurrently under identical conditions in the same room. The peculiar predisposition of the uPA- deficient animals to this rare bacterial infection and the development of phenotypic abnormalities associated with the targeted disruption the uPA gene suggests that uPA contributes significantly to the cutaneous microenvironment and is additional evidence of the extensive involvement of the plasminogen activators in mammalian physiology.

This article has been cited by other articles:

				S. C. Bryer, G. Fantuzzi, N. Van Rooijen, and T. J. Koh Urokinase-Type Plasminogen Activator Plays Essential Roles in Macrophage Chemotaxis and Skeletal Muscle Regeneration J. Immunol., January 15, 2008; 180(2): 1179 - 1188. [Abstract] [Full Text] [PDF]

				D. J. Webb, K. S. Thomas, and S. L. Gonias Plasminogen Activator Inhibitor 1 Functions as a Urokinase Response Modifier at the Level of Cell Signaling and Thereby Promotes Mcf-7 Cell Growth J. Cell Biol., February 19, 2001; 152(4): 741 - 752. [Abstract] [Full Text] [PDF]

				F.-M. Deng, M. Ding, R. M. Lavker, and T.-T. Sun Urothelial function reconsidered: A role in urinary protein secretion PNAS, January 2, 2001; 98(1): 154 - 159. [Abstract] [Full Text] [PDF]

				D. Webb, D. Nguyen, and S. Gonias Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion J. Cell Sci., January 1, 2000; 113(1): 123 - 134. [Abstract] [PDF]

				B. Degryse, M. Resnati, S. A. Rabbani, A. Villa, F. Fazioli, and F. Blasi Src-Dependence and Pertussis-Toxin Sensitivity of Urokinase Receptor-Dependent Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells Blood, July 15, 1999; 94(2): 649 - 662. [Abstract] [Full Text] [PDF]

				D. H.D. Nguyen, A. D. Catling, D. J. Webb, M. Sankovic, L. A. Walker, A. V. Somlyo, M. J. Weber, and S. L. Gonias Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner J. Cell Biol., July 12, 1999; 146(1): 149 - 164. [Abstract] [Full Text] [PDF]

				M. E. Dominiecki and J. Weiss Antibacterial Action of Extracellular Mammalian Group IIA Phospholipase A2 against Grossly Clumped Staphylococcus aureus Infect. Immun., May 1, 1999; 67(5): 2299 - 2305. [Abstract] [Full Text] [PDF]

				J. M. Beck, A. M. Preston, and M. R. Gyetko Urokinase-Type Plasminogen Activator in Inflammatory Cell Recruitment and Host Defense against Pneumocystis carinii in Mice Infect. Immun., February 1, 1999; 67(2): 879 - 884. [Abstract] [Full Text] [PDF]

				L. Zhang, D. K. Strickland, D. B. Cines, and A. A.-R. Higazi Regulation of Single Chain Urokinase Binding, Internalization, and Degradation by a Plasminogen Activator Inhibitor 1-Derived Peptide J. Biol. Chem., October 24, 1997; 272(43): 27053 - 27057. [Abstract] [Full Text] [PDF]

				O. Shliom, M. Huang, B. Sachais, A. Kuo, J. W. Weisel, C. Nagaswami, T. Nassar, K. Bdeir, E. Hiss, S. Gawlak, et al. Novel Interactions between Urokinase and Its Receptor J. Biol. Chem., August 4, 2000; 275(32): 24304 - 24312. [Abstract] [Full Text] [PDF]